Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Cellebrite DI Ltd (NASDAQ: CLBT) closed at $18.18 in the last session, up 0.41% from day before closing price of $18.1. In other words, the price has increased by $0.41 from its previous closing price. On the day, 0.96 million shares were traded. CLBT stock price reached its highest trading level at $18.34 during the session, while it also had its lowest trading level at $17.844.
Ratios:
We take a closer look at CLBT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.22 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 29.00. For the most recent quarter (mrq), Quick Ratio is recorded 1.90 and its Current Ratio is at 1.93. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Needham on March 28, 2024, Reiterated its Buy rating but revised its target price to $13.50 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on February 16, 2024, whereas the target price for the stock was revised from $9 to $12.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 06 ’25 when DANA GERNER bought 25,390 shares for $18.86 per share.
ALIAZAR KEINAN bought 508,790 shares of CLBT for $9,366,105 on Sep 24 ’25. On Sep 23 ’25, another insider, RONNEN ARMON, who serves as the Officer of the company, bought 40,535 shares for $17.97 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLBT now has a Market Capitalization of 4444448256 and an Enterprise Value of 3994595328. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.97 while its Price-to-Book (P/B) ratio in mrq is 10.66. Its current Enterprise Value per Revenue stands at 9.147 whereas that against EBITDA is 53.596.
Stock Price History:
The Beta on a monthly basis for CLBT is 1.30, which has changed by 0.0016528368 over the last 52 weeks, in comparison to a change of 0.13837254 over the same period for the S&P500. Over the past 52 weeks, CLBT has reached a high of $26.30, while it has fallen to a 52-week low of $13.10. The 50-Day Moving Average of the stock is 5.83%, while the 200-Day Moving Average is calculated to be -0.12%.
Shares Statistics:
According to the various share statistics, CLBT traded on average about 1.88M shares per day over the past 3-months and 1328070 shares per day over the past 10 days. A total of 239.47M shares are outstanding, with a floating share count of 108.89M. Insiders hold about 54.53% of the company’s shares, while institutions hold 39.78% stake in the company. Shares short for CLBT as of 1759190400 were 7430752 with a Short Ratio of 3.96, compared to 1756425600 on 5772027. Therefore, it implies a Short% of Shares Outstanding of 7430752 and a Short% of Float of 6.15.
Earnings Estimates
. The current market rating for Cellebrite DI Ltd (CLBT) reflects the collective analysis of 8.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.14, with high estimates of $0.16 and low estimates of $0.11.
Analysts are recommending an EPS of between $0.52 and $0.45 for the fiscal current year, implying an average EPS of $0.49. EPS for the following year is $0.52, with 8.0 analysts recommending between $0.59 and $0.46.
Revenue Estimates
According to 8 analysts,. The current quarter’s revenue is expected to be $122.98M. It ranges from a high estimate of $125M to a low estimate of $121M. As of. The current estimate, Cellebrite DI Ltd’s year-ago sales were $106.86MFor the next quarter, 8 analysts are estimating revenue of $125.95M. There is a high estimate of $129M for the next quarter, whereas the lowest estimate is $123.17M.
A total of 8 analysts have provided revenue estimates for CLBT’s current fiscal year. The highest revenue estimate was $473M, while the lowest revenue estimate was $465M, resulting in an average revenue estimate of $469.79M. In the same quarter a year ago, actual revenue was $401.2MBased on 8 analysts’ estimates, the company’s revenue will be $548.6M in the next fiscal year. The high estimate is $565M and the low estimate is $538.87M.
